Dr. Sangeeta Goswami
Claim this profileM D Anderson Cancer Center
Studies Bladder Cancer
Studies Urethral Cancer
2 reported clinical trials
2 drugs studied
Area of expertise
1Bladder Cancer
Stage IV
ARID1A positive
Stage III
2Urethral Cancer
Stage IV
ARID1A positive
Stage III
Affiliated Hospitals
Clinical Trials Sangeeta Goswami is currently running
Nivolumab
for Bladder Cancer
This phase II trial studies the effect of nivolumab in urothelial cancer that has spread to other places in the body (metastatic), specifically in patients with aberrations in ARID1A gene (ARID1A mutation) and correlate with expression level of CXCL13, an immune cytokine. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving nivolumab may help control the disease in patients with urothelial cancer or solid tumors. This trial aims at enriching patient selection based on genomic and immunological attributes of the tumor.
Recruiting2 awards Phase 217 criteria
DF6002 + Nivolumab
for Advanced Cancer
This trial is testing a new drug, DF6002, alone and with an existing drug, Nivolumab, in patients with advanced solid tumors. These patients have cancers that are hard to treat with standard methods. DF6002 might help shrink or slow down tumors, while Nivolumab boosts the immune system to fight cancer.
Recruiting1 award Phase 15 criteria
More about Sangeeta Goswami
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Sangeeta Goswami has experience with
- Nivolumab
- DF6002
Breakdown of trials Sangeeta Goswami has run
Bladder Cancer
Urethral Cancer
Urothelial Carcinoma
Urethral Carcinoma
Ureter Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sangeeta Goswami specialize in?
Sangeeta Goswami focuses on Bladder Cancer and Urethral Cancer. In particular, much of their work with Bladder Cancer has involved Stage IV patients, or patients who are ARID1A positive.
Is Sangeeta Goswami currently recruiting for clinical trials?
Yes, Sangeeta Goswami is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Sangeeta Goswami has studied deeply?
Yes, Sangeeta Goswami has studied treatments such as Nivolumab, DF6002.
What is the best way to schedule an appointment with Sangeeta Goswami?
Apply for one of the trials that Sangeeta Goswami is conducting.
What is the office address of Sangeeta Goswami?
The office of Sangeeta Goswami is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.